Cerebrolysin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Cerebrolysin (Enzymatically-treated porcine brain peptide extract) is a Multi-peptide neuroprotective compound. Extract of pig brain containing bioavailable neurotrophic factors including BDNF, GDNF, NGF, and CNTF. It is researched for cognitive improvement, neuroprotection, stroke recovery, traumatic brain injury recovery, dementia symptom reduction, memory improvement. Common dosages range from 5-30 mL daily administered once daily.
What Is Cerebrolysin?
Cerebrolysin (Enzymatically-treated porcine brain peptide extract) is a Multi-peptide neuroprotective compound. Extract of pig brain containing bioavailable neurotrophic factors including BDNF, GDNF, NGF, and CNTF. Also known as Cerebrolysin, porcine brain peptides, it has been studied for its potential effects on cognitive improvement, neuroprotection, stroke recovery, traumatic brain injury recovery, dementia symptom reduction, memory improvement.
The only multi-peptide neuroprotective compound approved for clinical use in Europe, with the largest body of human clinical trial data of any cognitive peptide. In the research community, Cerebrolysin has gained attention for its distinctive profile.
How Does Cerebrolysin Work?
Crosses the blood-brain barrier and promotes neurogenesis, neuroplasticity, and neuroprotection through endogenous neurotrophic signaling. Contains bioavailable BDNF and GDNF-like factors that directly support neural growth and synaptic function, enhance neuronal survival, and reduce apoptosis.
This multi-pathway activity helps explain why Cerebrolysin shows potential across several different applications.
What Does the Research Say About Cerebrolysin?
Randomized double-blind trials up to 28 weeks in Alzheimer's disease showed superiority to placebo on cognitive measures. Benefits also demonstrated in vascular dementia. 20+ clinical trials completed with thousands of subjects. Approved in Europe and Asia for neurological conditions.
Researchers should consult the latest peer-reviewed literature for the most current findings.
What Is the Recommended Cerebrolysin Dosage?
Standard Cerebrolysin dosing: 5-30 mL daily, administered once daily via intravenous injection.
Half-life: not established. Cycle length: 4-28 weeks depending on indication.
Use our peptide dosing calculator for exact reconstitution ratios.
Calculate Your Cerebrolysin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Cerebrolysin.
Open Calculator →What Are the Side Effects of Cerebrolysin?
Generally well-tolerated. Dizziness/vertigo most frequent adverse event. Mild headache and injection site reactions possible. Safe profile established across multiple long-duration clinical trials.
Cerebrolysin is not fda-approved in usa. approved in europe and asia for stroke, tbi, and dementia. limited availability in north america.
Can You Stack Cerebrolysin With Other Peptides?
Complements Dihexa (synaptogenesis) and Semax (BDNF upregulation) for comprehensive neuroprotection through multiple pathways.
What Is the Bottom Line on Cerebrolysin?
Cerebrolysin is a Multi-peptide neuroprotective compound researched for cognitive improvement, neuroprotection, stroke recovery, traumatic brain injury recovery, dementia symptom reduction, memory improvement. Standard protocols use 5-30 mL daily once daily for 4-28 weeks depending on indication.
Source from COA-tested vendors. Read our beginner's guide for more, or use the dosing calculator to plan your protocol.
Complete Guide
Cerebrolysin: What the Research Actually Shows
Related Reading
- Cerebrolysin Dosage Guide
- Cerebrolysin Benefits
- Cerebrolysin Side Effects
- Cerebrolysin Stacking Guide
- Cerebrolysin Cycle Guide
- Cerebrolysin Research
Research-Grade Sourcing
If you're going to research Cerebrolysin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Cerebrolysin?
Cerebrolysin (Enzymatically-treated porcine brain peptide extract) is a Multi-peptide neuroprotective compound. Extract of pig brain containing bioavailable neurotrophic factors including BDNF, GDNF, NGF, and CNTF. It is researched for cognitive improvement, neuroprotection, stroke recovery, traumatic brain injury recovery, dementia symptom reduction, memory improvement.
What is the recommended Cerebrolysin dosage?
Common dosages: 5-30 mL daily administered once daily via intravenous injection. Cycle length: 4-28 weeks depending on indication. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Cerebrolysin?
Generally well-tolerated. Dizziness/vertigo most frequent adverse event. Mild headache and injection site reactions possible. Safe profile established across multiple long-duration clinical trials.
Is Cerebrolysin safe?
Cerebrolysin has shown a favorable safety profile in research. Not FDA-approved in USA. Approved in Europe and Asia for stroke, TBI, and dementia. Limited availability in North America. All research should follow appropriate safety protocols.